NCT00814957View on ClinicalTrials.gov

An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

December 8, 2008

Primary Completion Date

June 11, 2009

Study Completion Date

June 11, 2009

Conditions

Substance Dependence

Interventions

DRUG

GSK618334

D3 receptor antagonist

Trial Locations (1)

HA1 3UJ

GSK Investigational Site, Harrow

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY